In this study, we found that FR-α is significantly overexpressed in gefitinib-resistant lung cancer cells, indicating that FA modification can enhance the targeting ability of milk exosomes towards these cells, thereby reducing off-target effects. Here, FOLR1 is linked to lung cancer.